Suchitra Kamle

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 26, 2026
CHI3L1 Expression in Chordoma: Implications for Immunotherapeutic Intervention.

Beatrice Campilan, Christian Godinez, Jonathan Arditi

|Sep 18, 2024
Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα- and CD24-Siglec10-Mediated Phagocytosis.

Bing Ma, Suchitra Kamle, Takayuki Sadanaga

|Aug 29, 2024
Retraction: Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3.

Chang-Min Lee, Chuan-Hua He, Jin Wook Park

|Apr 27, 2023
Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma.

Charlotte Guetta-Terrier, David Karambizi, Bedia Akosman

|Apr 10, 2023
Correction: Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3.

Chang-Min Lee, Chuan-Hua He, Jin Wook Park

Pageof 1